KD

Kiran Dhiraj Sarda

Active Director Designated Partner DIN 10605497
DIN 10605497 First appointment Apr 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Kiran Dhiraj Sarda

Data last updated:

Kiran Dhiraj Sarda is a Designated Partner at New Family Pharmacy Lifecare Llp (since 2024).

DIN 10605497
Primary Designation Designated Partner
First Appointment 26 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner26 Apr 20242024Active

Board colleagues of Kiran Dhiraj Sarda

NameDINCompanyDesignation
Chetan Balasaheb Mohite10605496New Family Pharmacy Lifecare LlpDesignated Partner
Vijay Dadasaheb Patil09471757New Family Pharmacy Lifecare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
New Family Pharmacy Lifecare Llp
Premium access

Shareholding and investment profile for Kiran Dhiraj Sarda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiran Dhiraj Sarda

Kiran Dhiraj Sarda currently holds 1 directorship: New Family Pharmacy Lifecare Llp (Designated Partner, since 26 Apr 2024).

Kiran Dhiraj Sarda was first appointed on 26 Apr 2024 as Designated Partner at New Family Pharmacy Lifecare Llp.

The current boards of Kiran Dhiraj Sarda's companies include Chetan Balasaheb Mohite (New Family Pharmacy Lifecare Llp), Vijay Dadasaheb Patil (New Family Pharmacy Lifecare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available